# Benchmark for Evaluating the Model

## 📊 Benchmark Details

**Name**: Benchmark for Evaluating the Model

**Overview**: The proposed benchmark evaluates the performance of models in predicting antibiotic resistance genes by integrating information from nucleotide sequences and biological text literature.

**Data Type**: text

**Domains**:
- Healthcare
- Natural Language Processing
- Bioinformatics

**Languages**:
- English

**Resources**:
- [Resource](N/A)

## 🎯 Purpose and Intended Users

**Goal**: To provide a comprehensive evaluation framework for predicting antibiotic resistance genes using integrated language models.

**Target Audience**:
- ML Researchers
- Bioinformatics Experts
- Healthcare Practitioners

**Tasks**:
- Text Classification

**Limitations**: N/A

## 💾 Data

**Source**: CARD and MEGARes v3 datasets

**Size**: 5,194 Reference Sequences from CARD, 9,733 Reference Sequences from MEGARes

**Format**: N/A

**Annotation**: Annotated based on existing databases including labeled classes for antibiotic resistance.

## 🔬 Methodology

**Methods**:
- Human evaluation
- Automated metrics

**Metrics**:
- Accuracy
- Macro F1 Score
- Precision
- Recall

**Calculation**: Metrics calculated based on performance on testing datasets, comparing predictions against actual labels.

**Interpretation**: Higher scores in accuracy and F1 reflect better performance in classifying antibiotic resistance.

**Baseline Results**: N/A

**Validation**: Validation involves checking the weighted soft voting ensemble model against a dedicated validation dataset.

## ⚠️ Targeted Risks

**Risk Categories**:
- Accuracy
- Fairness
- Privacy

**Atlas Risks**:
- **Accuracy**: Unrepresentative data
- **Fairness**: Data bias
- **Privacy**: Personal information in data

**Demographic Analysis**: N/A

**Potential Harm**: N/A

## 🔒 Ethical and Legal Considerations

**Privacy And Anonymity**: Not Applicable

**Data Licensing**: Not Applicable

**Consent Procedures**: Not Applicable

**Compliance With Regulations**: Not Applicable
